B01. Radiotherapy


This Clinical Reference Group (CRG) covers radiotherapy. Radiotherapy is the controlled use of high energy x-rays to treat many different types of cancer. In a few cases, radiotherapy can also be used to treat benign (non-cancerous) tumours. Radiotherapy may be used to cure an illness for example, by destroying a tumour (abnormal tissue); to control symptoms e.g. pain relief; to shrink a tumour to make it easier to remove, prior to surgery, and after surgery, to destroy small amounts of tumour that may be left.


Chair: Dr Imogen Locke
Carol Scott, clinical member
Dr Christopher Scrase, clinical member
Dr Christopher Walker, clinical member
Dr Petra Jankowska, clinical member
Dr Rachel Cooper, clinical member
Dr Ramkumar Shanmugasundaram, clinical member
Sarah Helyer, clinical member
Kim Fell
, lead commissioner
Matt Smith, Public Health England lead
Anthony Murphy, PPV
Georgina Wiley, PPV
Rose Gray, PPV


A key part of the CRG’s work is the delivery of the ‘products’ of commissioning. These are the tools used by the 10 Hub Commissioning Teams to contract services on an annual basis.

Service Specifications

Service specifications are important in clearly defining the standards of care expected from organisations funded by NHS England to provide specialised care. The specifications have been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe both core and developmental service standards. Core standards are those that all funded providers should be able to demonstrate, with developmental standards being those which may require further changes in practice over time to provide excellence in the field. The following service specifications fall within the scope of this CRG:


A commissioning policy is a document that defines access to a service for a particular group of patients. A NICE Technology Appraisal Guideline on the same topic will replace, or be incorporated into, a commissioning policy as appropriate. These are important documents that are developed to ensure consistency in access to treatments nationwide. The following policies fall within the scope of this CRG:

Policy statements

Policy statements are brief documents that define the current commissioning position to support service contracting. The following policy statements fall within the scope of this CRG:


Learning Health Care System for Radiotherapy Services in England

Learning Healthcare System (RT-LHS) was launched in partnership with the Royal College of Radiologists in October 2019. It brings together a collaboration of key national partners and the 11 new Radiotherapy Networks to deliver ambitious improvements in access and outcomes for patients together, and at pace. The RT-LHS Compact can be found here.


Commissioning through Evaluation

NHS England’s Commissioning through Evaluation (CtE) scheme for the use of Selective Internal Radiation Therapy (SIRT) to treat cancerous tumours in the liver is now complete.  The independent evaluation of the scheme, led by the National Institute for Health & Care Excellence (NICE) has now been published.  The evaluation will now be used to support a review of the currently published clinical commissioning policy statement on SIRT, which can be found above.



January 2019: Boy with rare brain cancer to be treated at new NHS £125 million centre

December 2018: First NHS cancer patient to begin treatment with state of the art proton beam therapy in Manchester

June 2016: Patients benefiting from advanced brain tumour treatment set to double (article includes a full list of stereotactic radiosurgery and radiotherapy [SRS/SRT] providers)